Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: outcomes of a dedicated anesthesia and surgery protocol

Keyphrases

• Anesthesia 100%
• Percutaneous Endoscopic Gastrostomy 100%
• Amyotrophic Lateral Sclerosis 100%
• Regional Anesthesia 20%
• Patient Demographics 10%
• Disease Progression 10%
• Associated Complications 10%
• Analgesia 10%
• Complication Rate 10%
• Operative Time 10%
• Dysphagia 10%
• Anesthetic Agents 10%
• Pulmonary Function 10%
• Pulmonary Function Test 10%
• Procedure Time 10%
• Endoscope 10%
• Preoperative Weight Loss 10%
• Protocol Implementation 10%
• Anesthesia Surgery 10%
• Patient Comorbidities 10%
• Thirty-day Readmission 10%
• Readmission Rates 10%
• Propofol 10%
• Preoperative Evaluation 10%
• 90-day Mortality 10%
• Total Weight Loss 10%
• Management Protocol 10%
• Liposomal Bupivacaine 10%
• Opioid Use 10%
• Dedicated Team 10%
• Hemidiaphragm 10%
• Anesthesia Time 10%
• Anesthesia Emergence 10%
• Aspiration Risk 10%
• Procedural Success Rate 10%
• Pulmonary Aspiration 10%
• Severe Malnutrition 10%
• Implementation Teams 10%

Medicine and Dentistry

• Amyotrophic Lateral Sclerosis 100%
• Percutaneous Endoscopic Gastrostomy 100%
• Regional Anesthesia 20%
• Operation Duration 10%
• Patient Population 10%
• Analgesia 10%
• Endoscope 10%
• Plummer-Vinson Syndrome 10%
• Anesthetic Agent 10%
• Disease Exacerbation 10%
• Lung Function 10%
• Lung Function Test 10%
• Surgical Site 10%
• Propofol 10%
• Preoperative Evaluation 10%
• Hemidiaphragm 10%
• Polyethylene Glycol 10%
• Bupivacaine 10%
• Pulmonary Aspiration 10%